MCL-1 is a prognostic indicator and drug target in breast cancer.
Campbell KJ, Dhayade S, Ferrari N, Sims AH, Johnson E, Mason SM, Dickson A, Ryan KM, Kalna G, Edwards J, Tait SWG, Blyth K.
Campbell KJ, et al. Among authors: kalna g.
Cell Death Dis. 2018 Jan 16;9(2):19. doi: 10.1038/s41419-017-0035-2.
Cell Death Dis. 2018.
PMID: 29339815
Free PMC article.